MMP-2 and MMP-9 secretion are decreased and the migration and invasion of HCC cells are inhibited when using the CD147 antibody, siRNA or other methods such as arsenic trioxide to down-regulate CD147 and MMP-2 [102]. The gene discussed is MMP2; the disease is hepatocellular carcinoma.